BNP Paribas Exane Upgrades Haleon (NYSE:HLN) to “Outperform”
Haleon (NYSE:HLN – Get Free Report) was upgraded by stock analysts at BNP Paribas Exane from a “neutral” rating to an “outperform” rating in a note issued to investors on Tuesday, MarketBeat reports. The firm presently has a $13.40 target price on the stock. BNP Paribas Exane’s target price points to a potential upside of […]
Haleon (NYSE:HLN – Get Free Report) was upgraded by stock analysts at BNP Paribas Exane from a “neutral” rating to an “outperform” rating in a note issued to investors on Tuesday, MarketBeat reports. The firm presently has a $13.40 target price on the stock. BNP Paribas Exane’s target price points to a potential upside of […]
